Who are Progesterone Vaginal Gel [Crinone]'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): PGL4001, progestin, PGL4001 matching placebo and iron, Progesteron TID, PGL4001, placebo, drug free period.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/progesterone-vaginal-gel-crinone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Progesterone Vaginal Gel [Crinone] — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Progesterone Vaginal Gel [Crinone] (Progesterone Vaginal Gel [Crinone]) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Progestin; Progesterone receptor agonist. Area: Reproductive/Fertility.

marketed Progestin; Progesterone receptor agonist Progesterone receptor (PR) Reproductive/Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Progesterone Vaginal Gel [Crinone] (Progesterone Vaginal Gel [Crinone]) — Memorial Sisli Hospital, Istanbul. Progesterone binds to progesterone receptors in the uterus to support the luteal phase and maintain pregnancy.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Progesterone Vaginal Gel [Crinone] TARGET	Progesterone Vaginal Gel [Crinone]	Memorial Sisli Hospital, Istanbul	marketed	Progestin; Progesterone receptor agonist	Progesterone receptor (PR)
PGL4001, progestin	PGL4001, progestin	PregLem SA	phase 3	Progestin (progesterone receptor agonist)	Progesterone receptor (PR)
PGL4001 matching placebo and iron	PGL4001 matching placebo and iron	PregLem SA	phase 3	Progesterone receptor agonist	Progesterone receptor (PR)
Progesteron TID	Progesteron TID	University Hospital, Ghent	phase 3	Progestin / Progesterone receptor agonist	Progesterone receptor (PR)
PGL4001, placebo, drug free period	PGL4001, placebo, drug free period	PregLem SA	phase 3	Progesterone receptor agonist	Progesterone receptor (PR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Progestin; Progesterone receptor agonist class)

Memorial Sisli Hospital, Istanbul · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Progesterone Vaginal Gel [Crinone] — Competitive Intelligence Brief. https://druglandscape.com/ci/progesterone-vaginal-gel-crinone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab